Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Integra LifeSciences Holdings Corporation before investing.

In this article, we go over a few key elements for understanding Integra LifeSciences Holdings Corporation’s stock price such as:

• Integra LifeSciences Holdings Corporation’s current stock price and volume
• Why Integra LifeSciences Holdings Corporation’s stock price changed recently
• Upgrades and downgrades for IART from analysts
• IART’s stock price momentum as measured by its relative strength

About Integra LifeSciences Holdings Corporation (IART)

Before we jump into Integra LifeSciences Holdings Corporation’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical, ear, nose, throat, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates through Codman Specialty Surgical and Tissue Technologies segments. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment. It also offers after-market services; surgical headlamps and instrumentation; instrument patterns and surgical and lighting products to hospitals, surgery centers, dental, podiatry, and veterinary offices. In addition, the company provides treatment of acute wounds, such as burns; chronic wounds, including diabetic foot ulcers; and surgical tissue repair applications, including hernia reinforcement, tendon protection, and peripheral nerve repair. Further, it offers skin and wound repair, plastics and surgical reconstruction products, and nerve and tendon repair products. Additionally, the company is involved in the ear, nose, and throat business that includes instrumentation, balloon technologies for sinus dilation and eustachian tube dilation, and surgical navigation systems. It offers its products directly through various salesforces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, the Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was formerly known as Integra LifeSciences Corp. and changed its name to Integra LifeSciences Holdings Corporation in June 1995. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.

Want to learn more about Integra LifeSciences Holdings Corporation’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Integra LifeSciences Holdings Corporation.

Integra LifeSciences Holdings Corporation’s Stock Price as of Market Close

As of July 31, 2026, 4:00 PM, CST, Integra LifeSciences Holdings Corporation’s stock price was $16.650.

Integra LifeSciences Holdings Corporation is down 2.75% from its previous closing price of $17.120.

During the last market session, Integra LifeSciences Holdings Corporation’s stock traded between $16.240 and $17.590. Currently, there are approximately 76.95 million shares outstanding for Integra LifeSciences Holdings Corporation.

Integra LifeSciences Holdings Corporation’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

Integra LifeSciences Holdings Corporation Stock Price History

Integra LifeSciences Holdings Corporation’s (IART) price is currently down 7.29% so far this month.

During the month of July, Integra LifeSciences Holdings Corporation’s stock price has reached a high of $20.490 and a low of $16.040.

Over the last year, Integra LifeSciences Holdings Corporation has hit prices as high as $20.490 and as low as $8.700. Year to date, Integra LifeSciences Holdings Corporation’s stock is up 34.06%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Integra LifeSciences Holdings Corporation Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of July 30, 2026, there was 1 analyst who downgraded Integra LifeSciences Holdings Corporation’s stock and 2 analysts who upgraded over the last month.

Additionally, you'll want to evaluate Integra LifeSciences Holdings Corporation’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Integra LifeSciences Holdings Corporation’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Integra LifeSciences Holdings Corporation’s current valuation based on AAII’s Value Grade is a D, which means it is considered to be Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Integra LifeSciences Holdings Corporation (IART) by visiting AAII Stock Evaluator.

Relative Price Strength of Integra LifeSciences Holdings Corporation

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of July 30, 2026, Integra LifeSciences Holdings Corporation has a weighted four-quarter relative price strength of 18.65%, which translates to a Momentum Score of 91 and is considered to be Very Strong.

Want to learn more about how Integra LifeSciences Holdings Corporation is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Integra LifeSciences Holdings Corporation Stock Price: Bottom Line

As of July 31, 2026, Integra LifeSciences Holdings Corporation’s stock price is $16.650, which is down 2.75% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Integra LifeSciences Holdings Corporation stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.